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1 Introduction
Neonatal lung disease after premature birth has
been associated with long term pulmonary seque-
lae. Bronchial hyperreactivity, e.g., has been
found in school children following long term ven-
tilation during the neonatal period [11] and fol-
lowing bronchopulmonary dysplasia [1, 15]. A
high incidence of airway hyperreactivity has also
been described in children after premature birth
without respiratory distress syndrome and in a
high proportion of their mothers and siblings born
at term [2]. As a relationship between familial
airway hyperreactivity and premature birth was
suggested by this work, it seemed important to
further investigate mothers of preterm infants. It
was the purpose of the present study to compare
bronchial responsiveness to histamine among
mothers of term infants and preterm infants with
known and with unknown causes for prematurity.
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2 Material and methods
Pulmonary function tests were performed in all
mothers of neonates admitted to our neonatal
ward during the years 1984—1987 provided in-
formed consent was obtained and the following
criteria were met:
Non-smoker for at least two years before preg-
nancy; no atopic disease (asthma, hay fever,
eczema) including first degree relatives; no chronic
lung disease; no acute airway infection during the
preceeding 6 weeks; serum IgE < 100 lU/ml (En-
zygnost ELISA, Behringwerke, Marburg, FRG);
negative Type I skin reactions by prick test to 10
common inhalation allgergens (house dust mite,
different pollen allergens, feathers, moulds).
The 60 mothers who participated in the study were
separated into three groups:
Group I, mothers of term neonates (> 37 weeks
of gestation) n = 20;
Group II, mothers of preterm neonates (< 37
weeks of gestation) with unknown cause of pre-
maturity (idiopathic) n = 18; Group III, mothers
of preterm neonates in whom premature labour
could be explained by some definite reason as
defined below, n = 22.
Groups II and III were recruited from consecutive
admissions in the years 1984—1987, whereas
group I came from consecutive admission only in
1987.
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As explanations for preterm delivery were ex-
cepted: Multiple pregnancy, young age (< 16
years) or advanced age (> 35 years), premature
rupture of the fetal membranes without labour,
abdominal trauma, intrauterine infection, abnor-
mal placentation, structural uterine abnormalities,
congenital malformations, EPH-gestosis, polyhy-
dramnion, severe maternal illness during preg-
nancy and Rhesus-incompatibility.
The gestational age of the neonates was deter-
mined on the day of birth using the Farr-criteria
Π-
Pulmonary function tests were performed at least
four weeks after delivery and included vital ca-
pacity, functional residual capacity, residual vol-
ume, airway resistance and thoracic gas volume
(bodyplethysmography) and forced expiratory
flow measurements as described elsewhere [12].
Bronchial reactivity was measured by unspecific
provocation testing with inhaled histamine using
a modified version of the protocol described by
Cockroft et al. [6]. Histamine dihydrochloride in
buffered saline was nebulized in a 10 Itr reservoir
by pressure nebulizer (Pari, Starnberg, FRG, par-
ticle size 0.5 —5mm, output 0.75 ml/min) with
increasing concentrations (0.5 — 1—2 — 4 — 8 mg/
ml). To fill the reservoir, 0.75 ml of histamine
solution and 120 sec of nebulization were neces-
sary. When the reservoir was filled, the nebulized
aerosol was inhaled by tidal ventilation through a
one way valve.
One and three minutes after the inhalation forced
expiratory maneuvers were performed using a
pneumotachygraph (Pneumoscreen, Maeger,
FRG) and the best of three attempts, i. e. with the
highest forced expiratory volume, was used for
analysis. The histamine concentration producing
a 20% fall in forced expiratory volumes in 1 sec-
ond (PC2o,FEv1) was determined from a semi-log-
arithmic dose-response curve.
All investigations were performed in the afternoon
when bronchial reactivity is at its low part of
circadian variation.
A PC2o,FEvrvalue < 8 mg/ml histamine was as-
sumed to represent airway hyperreactivity accord-
ing to population studies [4].
PC20.FEV, -figures were compared between the three
groups using the Wilcoxon-Mann-Whitney-test;
for comparison of the incidence of airway hyper-
reactivity (as defined above) we used FISCHER'S
exact test.
3 Results
Age and number of previous pregnancies did not
differ among the three groups as shown in the
table.
Basic pulmonary function tests were within nor-
mal limits in all investigated mothers, but bron-
chial reactivity differed significantly in group II
(PC2o5FEv1 = 4.25 (0.9-> 8.0) mg/ml histamine,
median and range) from both other groups (group
Ι, PC20.FEV, = > 8.0 (0.55-> 8.0) mg/ml,
ρ < 0.002; group III, PC2o,FEv1 = > 8.0 (1.5-
< 8.0) mg/ml, p < 0.05; figure)
Accordingly, the incidence of bronchial hyper-
reactivity was significantly higher in group II (12
of 18) than in group I (3 of 20, ρ < 0.02), the
latter corresponding to the normal incidence of
airway hyperreactivity in a healthy population [4],
Between group II and III the incidence of bron-
chial hyperreactivity was not statistically different
(p = 0.55), although more hyperreactive mothers
were found in group II (12 of 18 vs. 8 of 22).
One of the three mothers in group I with increased
bronchial reactivity (PC20,FEV! of 3.7 mg/ml hista-
mine) reported having had some mild uterine con-
tractions at 26th week of gestation which ceased
spontaneously.
Table I. Age and numbers of previous pregnancies among the three groups (not different).
Group I Group II Group III
Age (y)
(median, range)
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Figure 1. Unspecific bronchial reactivity on histamine
provocation (PC2o,FEv,) in mothers of term infants and
of newborns with explained and idiopathic prematurity,
expressed as single values (dot) and median (square)
with 95% confidence limit.
4 Discussion
Mothers with preterm delivery of unknown cause
(idiopathic prematurity) have a significantly in-
creased airway reactivity compared to both moth-
ers of term neonates and mothers of preterm neo-
nates with a defined cause of preterm delivery.
The high incidence of bronchial hyperreactivity in
mothers with preterm delivery of unknown origin
cannot be explained by one of the factors which
are known to be associated with increased bron-
chial reactivity (atopy, smoking, chronic lung dis-
ease, recent airway infection, etc.) as these factors
were part of the exclusion criteria for the study.
The effect of pregnancy on bronchial reactivity is
not known, but as bronchial reactivity was meas-
ured at least four weeks after delivery an influence
of pregnancy is unlikely.
Although due to strict exclusion criteria the num-
bers in each group are small, bronchial reactivity
is obviously highest in the mothers with unex-
plained prematurity. The WILCOXON test, which
we used for statistical analysis in addition to
FISCHER'S exact test, has its limitation due to zen-
sored values above PC2o,FEv, of 8 mg/ml histamine.
When using this method for measuring bronchial
reactivity, it does not seem justified to further
increase histamine concentrations in healthy
women above 8 mg/ml until significant bronchial
obstruction occurs, as non specific side effects
occur (e.g. cough, flush, throat irritation and
headache) under these circumstances before bron-
chial obstruction is observed.
One of the hypotheses about the pathogenesis of
bronchial hyperreactivity implies an imbalance
within the autonomic nervous system [3] which
has an important role in uterine innervation and
function [13]. Beta-2-agonists, the drugs of first
choice in bronchial asthma, are the main agents
for inhibition of premature labour [10]. Further-
more, the potent bronchoconstrictor Prostaglan-
din F2a [14], is one of the main mediators respon-
sible for cervical softening and uterine contrac-
tions in premature delivery [8].
Thus, a similar basic mechanism influencing uter-
ine and airway smooth muscle activity may be
operating in some women leading to airway hy-
perresponsiveness and premature labor.
As bronchial hyperreactivity is partly inherited [9],
airway hyperresponsiveness in the preterm neo-
nates of these mothers may not entirely be ex-
plained by acquired lung damage due to prema-
turity, oxygen treatment or neonatal ventilation,
but may also be related to a genetically determined
bronchial hyperreactivity.
This may also explain why premature infants, even
in the absence of BPD have a higher morbidity
following RSV- and other respiratory tract viral
infections [5]. They represent a risk group for later
bronchial disease, not due to early bronchial dam-
age but due to inherited bronchial hyperreagibility,
and should be followed up carefully in this regard.
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Zusammenfassung
Frühgcburtlichkeit und bronchiale Hypcrsensibilität bei
der Mutter
Bei Frühgeborenen beobachtet man in der Kindheit eine
höhere Prävalenz von bronchialer Hyperaktivität. Dis-
kutiert wird daher ein Zusammenhang zwischen Prä-
maturität und einer familiären Belastung hinsichtlich
bronchialer Hyperreaktionen. Wir haben die bronchiale
Reaktivität von drei Gruppen miteinander verglichen:
Mütter mit Reifgeborenen (Gruppe I, n = 20), Mütter
mit Frühgeburten unklarer Ursache (Gruppe II, n = 18)
und Mütter mit Frühgeburten bekannter Ätiologie
(Gruppe III, n = 22).
Mütter mit chronischen Lungenerkrankungen, atopi-
scher Disposition (Anamnese, IgE > 100 U/ml), gerade
abgelaufenen Infekten des Respirationstraktes sowie
Raucherinnen wurden ausgeschlossen. Die bronchiale
Reaktivität wurde über einen unspezifischen Provoka-
tionstest mit Histamin gemessen. Aus der Dosis-Ant-
wort-Kurve wurde die Histaminkonzentration berech-
net, die einen 20%igen Abfall der l-Sekunden-Kapazität
zur Folge hatte (PC2o,FEv1)·
Die Inzidenz von bronchialer Hyperreaktivität
(PC20,FEv1 < 8 mg/ml) war in Gruppe II (12 von 18)
höher als in Gruppe I (3 von 20, p < 0.02) und in Gruppe
III (8 von 22, p = 0.055). Darüberhinaus war der
PC2o,FEvrWert in Gruppe II signifikant niedriger (Me-
diän = 4,25 mg/ml) als in den beiden anderen Gruppen
(Mediane > 8 mg/ml, p < 0,05, Fig. 1). Zwischen
Gruppe I und Gruppe III gab es keine signifikanten
Unterschiede.
Die hohe Inzidenz von bronchialen Hypersensibilitäten
bei Müttern mit Frühgeburten unklarer Genese könnte
auf ein Ungleichgewicht innerhalb des autonomen Ner-
vensystems hinweisen, das Einfluß auf die Uterusmus-
kulatur und die glatte Muskulatur der Luftwege hat und
somit bronchiale Hyperreaktivität bedingt wie auch vor-
zeitige Wehen auslöst.
Neonatale Lungenaffektionen nach Frühgeburt wurden
mit Langzeitveränderungen an der Lunge in Zusammen-
hang gebracht. Bronchiale Hyperreaktivität ganz allge-
mein wurden bei Schulkindern nach Langzeitbeatmung
in der Neonatalphase [l 1] und nach bronchopulmonalen
Dysplasien [l, 15] gefunden. Auch bei Frühgeborenen
ohne RDS wurden später gehäuft Überempfindlichkei-
ten der Luftwege beschrieben. Dasselbe gilt für deren
Mütter und reifgeborene Geschwister [2]. Da auch die
vorliegende Arbeit auf einen Zusammenhang zwischen
familiärer Häufung von bronchialer Hyperreaktivität
und Frühgeburtlichkeit hinweist, sollten die Mütter von
Frühgeborenen genauer untersucht werden. Ziel dieser
Studie war der Vergleich der bronchialen Ansprechbar-
keit auf Histamin zwischen Müttern von Reifgeborenen
und Frühgeborenen, zum einen mit bekannter, zum an-
deren mit unbekannter Ursache für die Frühgeburtlich-
keit.
Schlüsselwörter: Bronchiale Hypersensibilität bei der Mutter, bronchialer Provokationstest, Frühgeburt.
Resume
Prematurite et hyperreactivite bronchique maternelle
II a ete montre que les nouveaux-nes prematures pre-
sentent une prevalence elevee d'hyperreactivite bron-
chique ulterieurement dans l'enfance, et il a ete suggere
une association entre prematurite et hyperreactivite
bronchique familiale.
Nous avons compare la reactivite bronchique des meres
ayant accouche prematurement sans cause (groupe II,
n = 18) avec celle de meres ayant accouche premature-
ment avec une cause connue de prematurite (groupe III,
n = 22) et celle de meres ayant accouche a terme (groupe
I, n = 20).
Nous avons exclu les meres ayant une pathologic pul-
monaire chronique, une disposition atopique (antece-
dents, IgE > 100 U/ml, test cutane positif), un taba-
gisme et des infections de l'arbre respiratoire recentes.
La reactivite bronchique a ete mesuree par des tests de
provocation bronchique non specifiques a rhistamine.
On a calcule a Paide d'une courbe dose-reponse
(PC2o,FEvt) la concentration qui entraine une baisse de
20% du volume expiratoire force en une seconde.
L'incidence de l'hyperreactivite bronchique (PCzo.FEV!
< 8 mg/ml) est plus elevee dans le groupe II (12/18) que
dans les deux autres groupes (vs groupe I = 3/20 = p
< 0,02; vs groupes III = 8/22 = p = 0,055). En outre,
la PC2o,FEV! dans ce groupe II est significativement plus
basse (4,25 mg/ml en moyenne) que dans les deux autres
groupes (moyennes 8 mg/ml, p 0,05; voir la figure). II
n'y a pas de difference significative dans la reactivite
bronchique entre les groupes I et III.
L'incidence elevee d'hyperreactivite bronchique chez les
meres ayant eu un accouchement premature inexplique
indique un desequilibre du Systeme nerveux autonome
influen^ant l'activite musculaire lisse de l'uterus et de
l'arbre respiratoire et conduisant a une hyperreactivite
bronchique ainsi qu'au travail premature.
Les affections pulmonaires neonatales apres accouche-
ment premature s'accompagnent de sequelles pulmo-
naires ä long terme. Par exemple, on a trouve une hy-
perreactivite bronchique chez les enfants scolarises suc-
cedant a une ventilation ä long terme au cours de la
periode neonatale [11] .et compliquant une dysplasie
broncho-pulmonaire [1, 15]. On a egalement decrit une
incidence elevee d'hyperreactivite de l'arbre respiratoire
chez des enfants nes prematurement sans syndrome de
detresse respiratoire ainsi que chez leus meres dans une
proportion elevee [2]. Comme une relation entre une
hyperreactivite familiale de l'arbre respiratoire et l'ac-
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couchement premature est suggeree par ce travail, il comparer la reponse bronchique a rhistamine des meres
semble important d'explorer ulterieurement les meres des d'enfants ä terme et d'enfants prematures ayant ou
enfants prematures. C'est l'objectif de cette etude de n'ayant pas de cause connue ä la prematurite.
Mots-cles: Accouchement premature, hyperreactivite bronchique maternelle, test de provocation bronchique.
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